Blood Test Study for Colorectal Cancer Patients
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Tempus AI · Industry
This trial is looking for patients with colorectal cancer who are having surgery for their cancer. Participants will provide blood samples to help with additional tests during their treatment and check-ups.
You may be able to join if
- I have been diagnosed with colorectal adenocarcinoma.
- I am 18 years old or older.
- I am willing to give my informed consent.
- I am willing to have blood samples taken during check-ups.
- I am planning to have surgery for my cancer or have already had surgery.
You may not be able to join if
- I am not willing to have additional blood samples collected.
- I have a type of cancer that is not colorectal adenocarcinoma.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.
Loading trial locations…